Early bird registration is open and closes May 2025. Register now

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s

APLAR Team

Abstract Submissions Extended

Due to strong interest, the abstract submission deadline for APLAR 2026 has been extended to 22 May 2026, providing additional time for authors to prepare and submit their work. This extension represents the final opportunity to be considered for inclusion in the APLAR 2026 scientific program. Please note that APLAR will not offer late abstract submissions this year. We encourage all prospective authors to take advantage of the extended deadline and submit their abstracts before submissions close. Presenting at APLAR

Read more →

Evening Symposium 5

Latest Evidence on Methotrexate and JAK Inhibitors Objectives: This session will discuss the combination therapy of JAK inhibitors with MTX and JAK inhibitors monotherapy. Agenda – Saturday 31 October Chairperson: Seong-Ho Kim 1730-1825 Latest Evidence on Methotrexate and JAK Inhibitors Yuko Kaneko

Read more →

Lunch Symposium 5

Objectives: Speaker will give comprehensive lecture for PMR patient management Disease characteristics and burden Diagnosis &Treatment guidelines and recommendations Unmet needs in PMR management Deliver biologics treatment value with urgency and important of symptom control for patient long-term life Agenda – Saturday 31 October Chairperson: Chan-Bum Choi 1300-1305 Opening Chan-Bum Choi 1305-1355 Polymyalgia Rheumatica: From Diagnosis to Long-Term Disease Control – Current Recommendations and Unmet Needs Frank Buttgereit 1355-1415 Q&A Chan-Bum Choi 1415-1420 Closing remarks Chan-Bum Choi

Read more →

APLAR 2026 Accommodation – Plan Ahead & Book Early

Delegates planning to attend APLAR 2026 in Seoul, Republic of Korea, are encouraged to book their accommodation early to secure the best availability and rates. A range of official congress hotels has been carefully selected and is conveniently located close to the congress venue, offering competitive rates and flexible booking conditions. With strong early interest in APLAR 2026 and continued global demand for international travel, accommodation in Seoul is expected to fill quickly. Booking early provides peace of mind and greater choice, and

Read more →

Back in 2026 – Rolling review

BACK IN 2026! In 2026, APLAR is continuing the rolling review of all abstract submissions. This means that you will be able to receive your submission result ahead of the submission deadline. We anticipate being able to advise your preliminary submission result within a couple weeks after completing your submission. What does this mean for you?

Read more →

Morning Symposium 2

Belimumab: 15 Years of Changing the Lupus Treatment Paradigm Session information coming soon. Agenda – Friday 30 October Workshop chairperson: TBC Presentation title TBC Yoshiya Tanaka TBC Presentation title TBC Hiroaki Niiro

Read more →

Key dates

Registrations
Abstracts
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.